Doug Hampton

Cold Plasma Market to grow by USD 1,790.8 million from 2022 to 2027; The increasing demand for eco-friendly and sustainable technologies drives the market

by

NEW YORK, Nov. 7, 2023 /PRNewswire/ — The cold plasma market is set to grow by USD 1,790.8 million from 2022 to 2027, progressing at a CAGR of 14.42% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The increasing demand for eco-friendly … Read more

Update relating to LEQEMBI® from Eisai’s investor presentation of their quarterly report published today

by

STOCKHOLM, Nov. 7, 2023 /PRNewswire/ — BioArctic AB’s (publ) (NASDAQ; BIOA B) (Stockholm: BIOA B) partner Eisai today held a presentation on the second quarter of Eisai’s fiscal year, ending March 2024. In addition to presenting sales numbers of 0.4 billion yen for LEQEMBI for the period, Eisai also stated the following; The launch of … Read more

Designs for Health Launches Innovative Probiotic Toothpaste, PerioBiotic™ Silver

by

Leading supplement brand debuts the only probiotic toothpaste suitable for sensitive teeth PALM COAST, Fla., Nov. 6, 2023 /PRNewswire/ — Designs for Health, the expert-recommended and preferred brand for high-quality, professional strength, research-backed supplements, and recipient of the 2023 Top Nutraceutical Company award** today announced the launch of PerioBiotic™ Silver, a fluoride-free probiotic toothpaste formulated with … Read more

Pharmaceutical packaging market size to grow by USD 48.88 billion from 2022 to 2027, The rise in R&D spending in the pharmaceutical industry to drive the market growth

by

NEW YORK, Nov. 5, 2023 /PRNewswire/ — The global pharmaceutical packaging market size is estimated to grow by USD 48.88 billion from 2022 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 8.44%. The rise in R&D spending in the pharmaceutical industry is driving market growth. Pharmaceutical companies are investing heavily in … Read more

Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy

by

SHANGHAI, Nov. 4, 2023 /PRNewswire/ — On October 26, 2023, KangaBio announced that the U.S. FDA has granted official approval for their independent R&D clinical trial application (IND) for KGX101. KGX101 is a recombinant IL-12 Fc fusion protein designed for intravenous injection. The KGX101 clinical trials will be carried out simultaneously in both United States … Read more

Ironside HR, No. 7 on the 2023 SMU D100 List

by

DALLAS, Nov. 3, 2023 /PRNewswire/ — Ironside Human Resources was named as Placeholder No. 7 last night during the Annual Dallas 100 Entrepreneur Awards Gala hosted by the SMU Cox School of Business. The gala took place at the Hyatt Regency in Dallas. Representatives from each of the recognized companies were present at the event. … Read more

Rising Demand for Value-Based Care Propels Growth in Healthcare Operational Analytics Market

by

DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Healthcare Operational Analytics Market Size & Share Analysis – Growth Trends & Forecasts (2023 – 2028)” report has been added to  ResearchAndMarkets.com’s offering. The global healthcare operational analytics market, estimated at USD 10.7 billion in 2022, is on track to achieve remarkable growth, projected to reach USD 22.4 … Read more

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting

by

Updated data from the Phase I trial of RVU120 in relapsed/refractory acute myeloid leukemia (r/r AML) or high-risk myelodysplastic syndromes (HR-MDS) demonstrate clinically relevant benefit in 50% of evaluable patients Preclinical data support RVU120 as a novel agent for the treatment of patients with lower-risk MDS (LR-MDS) and show cytotoxic and differentiating effects on leukemic stem cells … Read more

Jazz Pharmaceuticals to Participate in Upcoming November Investor Conferences

by

DUBLIN, Nov. 1, 2023 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference on Tuesday, November 14, 2023 Fireside chat at 4:30 a.m. PT / 7:30 a.m. ET / 12:30 p.m. GMT 6th Annual Evercore ISI HealthCONx Conference on Tuesday, … Read more

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market

by

DUBLIN, Oct. 31, 2023 /PRNewswire/ — The “Recombinant DNA Technology: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Recombinant DNA Technology estimated at US$64.7 Billion in the year 2022, is projected to reach a revised size of US$93.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period … Read more